Lumiracoxib (rINN) is a carboxylic acid COX-2 selective inhibitor non-steroidal anti-inflammatory drug manufactured by Novartis and still sold in few countries including Mexico Ecuador and the Dominican Republic under the trade name Prexige (sometimes misquoted as Prestige by the media).Lumiracoxib has several distinctive features.
This page contains content from the copyrighted Wikipedia article "Lumiracoxib"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
